Deborah B. Diercks

ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Excluded): 2021 Update

ACR Appropriateness Criteria® Major Blunt Trauma

Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction

Risk Stratification of Older Adults Who Present to the Emergency Department With Syncope: The FAINT Score

Comparison of 30-Day Serious Adverse Clinical Events for Elderly Patients Presenting to the Emergency Department With Near-Syncope Versus Syncope

Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial

Gender-specific Research for Emergency Diagnosis and Management of Ischemic Heart Disease: Proceedings from the 2014<i>Academic Emergency Medicine</i>Consensus Conference Cardiovascular Research Workgroup

Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial

Abstract 13996: Does Copeptin Provide Additional Risk Stratification in Chest Pain Patients With a Mild Troponin Elevation?

Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction

Impact of Society of Cardiovascular Patient Care Accreditation on Quality

What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?